Literature DB >> 3595590

Antibacterial activity of sucralfate and bismuth subsalicylate in simulated gastric fluid.

I Kappstein, I Engels.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595590     DOI: 10.1007/bf02018225

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  Campylobacter pyloridis and gastritis.

Authors:  B J Marshall
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

2.  Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway.

Authors:  G C du Moulin; D G Paterson; J Hedley-Whyte; A Lisbon
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

3.  Stomach as source of bacteria colonising respiratory tract during artificial ventilation.

Authors:  S T Atherton; D J White
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

4.  Duodenal ulcers that will not heal.

Authors:  R E Pounder
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

5.  Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in patients who are critically ill.

Authors:  E Borrero; S Bank; I Margolis; N D Schulman; R Chardavoyne
Journal:  Am J Med       Date:  1985-08-30       Impact factor: 4.965

6.  Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.

Authors:  S K Lam; N W Lee; J Koo; W M Hui; K H Fok; M Ng
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

7.  Alteration of normal gastric flora in critical care patients receiving antacid and cimetidine therapy.

Authors:  L G Donowitz; M C Page; B L Mileur; S H Guenthner
Journal:  Infect Control       Date:  1986-01

8.  [The effect of stress ulcer prevention on the incidence of pneumonia in artificial respiration].

Authors:  F Daschner; K Reuschenbach; J Pfisterer; I Kappstein; W Vogel; N Krieg; H Just
Journal:  Anaesthesist       Date:  1987-01       Impact factor: 1.041

  8 in total
  8 in total

1.  Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate.

Authors:  W A Krueger; G Ruckdeschel; K Unertl
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

Review 2.  Controversies in hospital infection control.

Authors:  F D Daschner; U Frank
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

3.  Antibacterial activity of sucralfate versus aluminum chloride in simulated gastric fluid.

Authors:  L Welage; P Carver; K Welch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

4.  Antibacterial activity of sucralfate against Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa in batch and continuous culture.

Authors:  A P West; S Abdul; M J Sherratt; T J Inglis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-11       Impact factor: 3.267

5.  Inhibition of bacterial adherence on the surface of stents and bacterial growth in bile by bismuth dimercaprol.

Authors:  Hongjun Zhang; Javon Tang; Xangwen Meng; Jackie Tsang; Tat-Kin Tsang
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

6.  In vitro antibacterial activity of sucralfate.

Authors:  D Bergmans; M Bonten; C Gaillard; F van Tiel; S van der Geest; E Stobberingh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

Review 7.  Hospital-acquired pneumonia: overview of the current state of the art for prevention and control.

Authors:  R P Wenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

8.  Binding and killing of bacteria by bismuth subsalicylate.

Authors:  T E Sox; C A Olson
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.